Finding Early Signs of Parkinson’s in the Blood

Recent research from the Cyprus Institute of Neurology and Genetics has found a new way to spot the early stages of the condition by looking at a special "signature" in our blood. The study, supported by the Michael J. Fox Foundation, focused on mitochondria—the tiny powerhouses inside our cells that create the energy we need to move and think. Inside these powerhouses is a small amount of DNA. The researchers discovered that in people with early-onset Parkinson's, this DNA has specific chemical markers that act like tiny "on and off" switches. This process is called methylation. Think of it as a layer of dust that settles on the switches; if there is too much or too little in certain places, it changes how the energy powerhouses work. The team used advanced technology to read these DNA switches in the blood of 39 people with the condition and 63 people without it. They found that people with the condition had a much higher overall level of these chemical markers. Interestingly, in one specific part of the DNA that controls how the powerhouses reboot themselves, the levels were actually lower. This discovery is important because it offers hope for a simple blood test that could help doctors identify the condition much earlier than they can today. Currently, we often have to wait for physical symptoms like tremors to appear before a diagnosis is made. By finding these "energy switches" in the blood, scientists might be able to track the condition more accurately and test if new treatments are actually protecting our brain cells.